tiprankstipranks
Creative Medical advances FDA cleared ADAPT trial with independent review
PremiumThe FlyCreative Medical advances FDA cleared ADAPT trial with independent review
3M ago
Creative Medical Technology files to sell 837,104 shares of common for holders
Premium
The Fly
Creative Medical Technology files to sell 837,104 shares of common for holders
3M ago
Creative Medical to sell 418,552 shares at $4.42 in registered direct offering
Premium
The Fly
Creative Medical to sell 418,552 shares at $4.42 in registered direct offering
4M ago
Creative Medical gets FDA authorization for CELZ-201 expanded access therapy
PremiumThe FlyCreative Medical gets FDA authorization for CELZ-201 expanded access therapy
12M ago
Creative Medical Technology gets orphan drug designation from FDA for CELZ-101
Premium
The Fly
Creative Medical Technology gets orphan drug designation from FDA for CELZ-101
12M ago
Creative Medical Technology’s CELZ-101 granted FDA orphan designation
Premium
The Fly
Creative Medical Technology’s CELZ-101 granted FDA orphan designation
12M ago
Creative Medical Technology Soars after Positive Drug Data
PremiumMarket NewsCreative Medical Technology Soars after Positive Drug Data
2y ago
Creative Medical Technology’s CELZ-001 shows positive results in diabetes
Premium
The Fly
Creative Medical Technology’s CELZ-001 shows positive results in diabetes
2y ago
Creative Medical Technology price target lowered to $7 from $10 at Roth MKM
Premium
The Fly
Creative Medical Technology price target lowered to $7 from $10 at Roth MKM
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100